LivaNova (LIVN) Operating Leases (2019 - 2026)
LivaNova (LIVN) reported Operating Leases of $46.7 million for Q1 2026, up 15.79% on a YoY basis from $40.3 million in Q1 2025, and down 3.37% sequentially from $48.3 million in Q4 2025.
LivaNova (LIVN) Operating Leases (2019 - 2026) Analysis & Trends
LivaNova (LIVN) has 8 years of Operating Leases data on file, last reported at $46.7 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 15.79% year-over-year to $46.7 million; the trailing twelve-month figure through Mar 2026 stood at $46.7 million (up 15.79% YoY), and the FY2025 full-year result was $48.3 million, up 20.5% from the prior year.
- Operating Leases fell to $46.7 million in Q1 2026, from $48.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $53.8 million in Q4 2023 to a low of $25.2 million in Q3 2023.
- A 5-year average of $38.7 million and a median of $40.3 million in 2025 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases declined 27.06% in 2022 and jumped 74.97% in 2024, its largest moves.
- Tracing LIVN's Operating Leases over 5 years: stood at $38.9 million in 2022, then surged by 38.08% to $53.8 million in 2023, then decreased by 25.39% to $40.1 million in 2024, then gained by 20.5% to $48.3 million in 2025, then decreased by 3.37% to $46.7 million in 2026.
- Business Quant data shows LIVN's Operating Leases at $46.7 million in Q1 2026, $48.3 million in Q4 2025, and $43.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.70 Mn |
| Dec 31, 2025 | 48.33 Mn |
| Sep 30, 2025 | 43.08 Mn |
| Jun 30, 2025 | 42.78 Mn |
| Mar 31, 2025 | 40.33 Mn |
| Dec 31, 2024 | 40.11 Mn |
| Sep 30, 2024 | 44.08 Mn |
| Jun 30, 2024 | 43.51 Mn |
| Mar 31, 2024 | 43.72 Mn |
| Dec 31, 2023 | 53.75 Mn |
| Sep 30, 2023 | 25.19 Mn |
| Jun 30, 2023 | 27.23 Mn |
| Mar 31, 2023 | 28.78 Mn |
| Dec 31, 2022 | 38.93 Mn |
| Sep 30, 2022 | 28.24 Mn |
| Jun 30, 2022 | 31.86 Mn |
| Mar 31, 2022 | 30.88 Mn |
| Dec 31, 2021 | 47.18 Mn |
| Sep 30, 2021 | 38.69 Mn |
| Jun 30, 2021 | 42.72 Mn |